Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5078-55-7

Post Buying Request

5078-55-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5078-55-7 Usage

Family

Pyrazole family of organic compounds

Building block

Used in the synthesis of more complex organic molecules

Structure

Contains a pyrazole ring, a methyl group at position 5, a nitrophenyl group at position 1, and an ethanone group

Applications

Pharmaceutical research and drug development

Potential

Bioactivity and ability to modulate biological systems

Studies

Investigated for potential pharmacological properties

Fields of application

Medicine and biotechnology

Check Digit Verification of cas no

The CAS Registry Mumber 5078-55-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,7 and 8 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5078-55:
(6*5)+(5*0)+(4*7)+(3*8)+(2*5)+(1*5)=97
97 % 10 = 7
So 5078-55-7 is a valid CAS Registry Number.

5078-55-7Relevant articles and documents

N -[6-(4-Butanoyl-5-methyl-1 H -pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1 H -indole-3-carboxamide (SAR216471), a Novel Intravenous and Oral, Reversible, and Directly Acting P2Y12 Antagonist

Boldron, Christophe,Besse, Angélina,Bordes, Marie-Fran?oise,Tissandié, Stéphanie,Yvon, Xavier,Gau, Benjamin,Badorc, Alain,Rousseaux, Tristan,Barré, Guillaume,Meneyrol, Jér?me,Zech, Gernot,Nazare, Marc,Fossey, Valérie,Pflieger, Anne-Marie,Bonnet-Lignon, Sandrine,Millet, Laurence,Briot, Christophe,Dol, Frédérique,Hérault, Jean-Pascal,Savi, Pierre,Lassalle, Gilbert,Delesque, Nathalie,Herbert, Jean-Marc,Bono, Fran?oise

, p. 7293 - 7316 (2015/01/08)

In the search of a potential backup for clopidogrel, we have initiated a HTS campaign designed to identify novel reversible P2Y12 antagonists. Starting from a hit with low micromolar binding activity, we report here the main steps of the optimization process leading to the identification of the preclinical candidate SAR216471. It is a potent, highly selective, and reversible P2Y12 receptor antagonist and by far the most potent inhibitor of ADP-induced platelet aggregation among the P2Y12 antagonists described in the literature. SAR216471 displays potent in vivo antiplatelet and antithrombotic activities and has the potential to differentiate from other antiplatelet agents.

Synthesis and Structures of Pyrazoles from Ethoxymethylene Derivatives of 1,3-Dicarbonyl Compounds and Hydrazines

Nagarajan, Kuppuswamy,Arya, Vishwa Prakash,Shenoy, Sharada J.

, p. 1401 - 1443 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5078-55-7